+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Plaquenil"

Hydroxychloroquine Global Market Report 2024 - Product Thumbnail Image

Hydroxychloroquine Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Global Hydroxychloroquine Sulphate Market Outlook 2026 - Product Thumbnail Image

Global Hydroxychloroquine Sulphate Market Outlook 2026

  • Report
  • May 2020
  • 117 Pages
  • Global
From
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Plaquenil is a brand name for the generic drug hydroxychloroquine, an immune disorder drug used to treat and prevent malaria. It is also used to treat rheumatoid arthritis, lupus, and porphyria cutanea tarda. Plaquenil works by reducing inflammation and suppressing the immune system. It is usually taken orally, but can also be administered intravenously. Common side effects include nausea, vomiting, and headache. Plaquenil is a widely used drug in the treatment of immune disorders. It is often prescribed as a first-line treatment for rheumatoid arthritis and lupus, and is also used to treat other autoimmune diseases. It is generally well-tolerated and has few serious side effects. The Plaquenil market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more